Section A: Anatomy and Physiology of Human Nervous System -- Chapter 1. Nanocarriers as an emerging tool for drug delivery to combat neurodegenerative diseases -- Chapter 2. Challenges in drug development for neurological disorders -- Chapter 3. Transporter systems and metabolism at the blood-brain barrier and blood-CSF barrier -- Section B: Pathophysiology and management of Neurological disorders -- Chapter 4. Pathophysiology and management approaches for Alzheimer's Disease -- Chapter 5. Pathophysiology and management approaches for Parkinson's Disease -- Chapter 6 Pathophysiology and management approaches for Epilepsy -- Chapter 7. Pathophysiology and management approaches for Epilepsy -- Chapter 8. Pathophysiology and management approaches for Multiple Sclerosis, Huntington's disease, and other neurodegenerative diseases -- Chapter 9. Genes Encoding Ion Channels in Neurotherapeutics: Opportunities and Challenges -- Chapter 10. Herbal approaches for the management of neurological disorders -- Section C: Drug Delivery Strategies in Neurological disorders -- Chapter 11. Essential Considerations for brain delivery of nanoformulations -- Chapter 12. Drug delivery strategies in Alzheimer's disease -- Chapter 13. Drug delivery strategies in Parkinson's disease -- Chapter 14. Drug delivery strategies in Epilepsy -- Chapter 15. Drug delivery strategies in Traumatic Brain Injury -- Chapter 16. Drug delivery strategies in Multiple Sclerosis, Huntington's disease, and other neurodegenerative diseases -- Chapter 17. Nose-to-brain strategies for neurological disorders -- Chapter 18. Drug delivery strategies for the delivery of natural compounds to the brain.